Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07062523Phase 2Recruiting
Phase 2, open-label trial (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Optimal imaging time up to 3 months, Correlation with inflammatory markers at 6 weeks and 1 more. Started Jul 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07062523.